QT
EBS icon

Quantbot Technologies’s Emergent Biosolutions EBS Stock Holding History

Quantbot Technologies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-461
Closed -$3.83K – 1995
2026
Q1 		$3.83K Buy
+461
New +$4.78K ﹤0.01% 1587
2024
Q2 		– Sell
-4,930
Closed -$12.5K – 1568
2024
Q1 		$12.5K Sell
4,930
-28,870
-85% -$65.1K ﹤0.01% 1444
2023
Q4 		$81.1K Buy
33,800
+25,100
+289% +$59K ﹤0.01% 1234
2023
Q3 		$29.6K Buy
8,700
+5,970
+219% +$33.1K ﹤0.01% 1316
2023
Q2 		$20.1K Sell
2,730
-18,800
-87% -$174K ﹤0.01% 1418
2023
Q1 		$223K Buy
21,530
+15,730
+271% +$190K 0.02% 876
2022
Q4 		$68.5K Buy
+5,800
New +$89.8K ﹤0.01% 1241
2022
Q3 		– Sell
-8,629
Closed -$267K – 1704
2022
Q2 		$267K Buy
8,629
+5,764
+201% +$197K 0.02% 814
2022
Q1 		$117K Buy
+2,865
New +$126K 0.01% 1002
2021
Q4 		– Sell
-2,110
Closed -$105K – 1612
2021
Q3 		$105K Buy
+2,110
New +$128K 0.01% 954
2021
Q1 		– Sell
-749
Closed -$67K – 1496
2020
Q4 		$67K Sell
749
-619
-45% -$56.8K 0.01% 815
2020
Q3 		$141K Buy
+1,368
New +$147K 0.02% 662
2019
Q4 		– Sell
-1,300
Closed -$67K – 1292
2019
Q3 		$67K Buy
+1,300
New +$60.6K 0.01% 917
2018
Q3 		– Sell
-1,080
Closed -$54K – 1316
2018
Q2 		$54K Buy
+1,080
New +$56.3K ﹤0.01% 975
2017
Q4 		– Sell
-679
Closed -$27K – 1258
2017
Q3 		$27K Buy
679
+385
+131% +$13.9K ﹤0.01% 1026
2017
Q2 		$9K Sell
294
-11,952
-98% -$369K ﹤0.01% 1036
2017
Q1 		$355K Buy
12,246
+11,525
+1,598% +$351K 0.04% 497
2016
Q4 		$23K Buy
+721
New +$21.6K ﹤0.01% 918
2014
Q3 		– Sell
-3,400
Closed -$76K – 1190
2014
Q2 		$76K Buy
3,400
+2,700
+386% +$62.9K 0.01% 824
2014
Q1 		$17K Buy
+700
New +$17.7K ﹤0.01% 978

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Quantbot Technologies's EBS Position: Q2 2026 in Review

Quantbot Technologies sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 461 shares — an estimated $3.83K sold.

Quantbot Technologies first reported a position in EBS in Q1 2014 and held it in 20 quarters. The position peaked at $355K in Q1 2017. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Quantbot Technologies reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 461 Emergent Biosolutions shares in Q2 2026, an estimated $3.83K.
  • Quantbot Technologies first reported a position in Emergent Biosolutions in Q1 2014 and held it in 20 quarters.
  • Quantbot Technologies's Emergent Biosolutions position peaked at $355K in Q1 2017.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.